Diagnostic Accuracy of Molecular Detection of Mycobacterium Tuberculosis in Pediatric Stool Samples: A Systematic Review and Meta-analysis
Overview
Pulmonary Medicine
Affiliations
Background: Stool is a promising specimen option to diagnose pediatric tuberculosis (TB), but studies have reported a wide range of test sensitivities. We conducted a meta-analysis to assess the accuracy of Xpert MTB/RIF or 'in-house' molecular tests on stool samples against culture or Xpert MTB/RIF on respiratory samples or clinically-diagnosed unconfirmed TB and aimed to identify factors that contribute to the heterogeneity of reported sensitivity.
Methods: We searched EMBASE and Pubmed databases and conference abstract books for studies reporting molecular stool testing against a clinical or microbiological reference standard among children.
Results: We identified 16 studies that included 2,481 children in stool test analyses. Pooled specificity was 98% [95%CI: 96-99], pooled sensitivity was 57% [95%CI: 40-72] against culture and 3% [95%CI: 2-6] among children with clinically-diagnosed, unconfirmed TB. There was much heterogeneity. Sensitivity was higher among children with a smear-positive sputum test. Rifampin resistance in stool was reported in two studies and detected in 5/14 children (36%).
Conclusion: Our results suggest molecular stool tests have potential as diagnostic rule-in tests, but it is challenging to optimize sensitivity due to between-study variation in methodology and test procedures. Therefore, we recommend future research with rigorous study design and standardized results reporting.
A critical perspective on paediatric pulmonary tuberculosis and diagnostic advancements.
Mochankana K, Masekela R Afr J Thorac Crit Care Med. 2025; 30(4):e2883.
PMID: 40041415 PMC: 11874177. DOI: 10.7196/AJTCCM.2024.v30i4.2883.
Klinkenberg E, de Haas P, Manyonge C, Namutebi J, Mujangi B, Mutunzi H Emerg Infect Dis. 2025; 31(3):1-9.
PMID: 40023826 PMC: 11878326. DOI: 10.3201/eid3103.241580.
Kasule G, Hermans S, Semugenze D, Wekiya E, Nsubuga J, Mwachan P Eur J Med Res. 2024; 29(1):502.
PMID: 39420420 PMC: 11487833. DOI: 10.1186/s40001-024-02092-z.
Innovative COVID-19 Point-of-Care Diagnostics Suitable for Tuberculosis Diagnosis: A Scoping Review.
Holtgrewe L, Jain S, Dekova R, Broger T, Isaacs C, Theron G J Clin Med. 2024; 13(19).
PMID: 39407954 PMC: 11477317. DOI: 10.3390/jcm13195894.
Detection of Mycobacterium tuberculosis transrenal DNA in urine samples among adults in Peru.
Mesman A, Calderon R, Hauns L, Pollock N, Mendoza M, Holmberg R Tuberculosis (Edinb). 2024; 148:102549.
PMID: 39098064 PMC: 11381138. DOI: 10.1016/j.tube.2024.102549.